Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Oren Hershkovitz"'
Autor:
Chen Ankri, Oren Hershkovitz, Liat Hershkovitz, Meital Brami, Ronnie Levy, Hadar Sarig, Einat Souli, Barak Reicher, Veronique Amor-Baroukh, Dror Mevorach, Abraham Nyska
Publikováno v:
Pharmaceutics, Vol 16, Iss 3, p 426 (2024)
Apoptotic cells possess immunomodulatory effects that can be utilized to treat imbalanced immune conditions. Information on the preclinical safety of such treatment is sparse. In this study, the safety of apoptotic cells (Allocetra-OTS) was assessed
Externí odkaz:
https://doaj.org/article/484daee91bb9477a925e671ae104f69b
Autor:
Peter Vernon van Heerden, Avraham Abutbul, Ahmad Naama, Shlomo Maayan, Nassar Makram, Akiva Nachshon, Kamal abu Jabal, Oren Hershkovitz, Lior Binder, Yehudit Shabat, Barak Reicher, Dror Mevorach
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundHyper-inflammatory immune response, a hallmark of severe COVID-19, is associated with increased mortality. Acute respiratory distress syndrome (ARDS) is a common manifestation. We undertook two phase I/II studies in five and then 16 subject
Externí odkaz:
https://doaj.org/article/e29d0b2a646945f09b490ac645c1c130
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Eyal Fima, L'udmila Trejbalová, Laszlo Bajnok, Ronit Koren, Leanne Amitzi, Christian J. Strasburger, Miklós Góth, Janos Vadasz, Juraj Payer, Peter Vanuga, Marija Pfeifer, Martin Bidlingmaier, Gili Hart, Veˇra Olšovská, Beverly M. K. Biller, Oren Hershkovitz, Vera Popovic
Publikováno v:
European Journal of Endocrinology
Objective Growth hormone (GH) replacement therapy currently requires daily injections, which may cause distress and low compliance. C-terminal peptide (CTP)-modified growth hormone (MOD-4023) is being developed as a once-weekly dosing regimen in pati
Autor:
Laura Moschcovich, Ron G. Rosenfeld, Eyal Fima, Yana Felikman, Vivian Hwa, Ahuva Bar-Ilan, Rachel Guy, Oren Hershkovitz, Gili Hart
Publikováno v:
Molecular Pharmaceutics. 13:631-639
MOD-4023 is a novel long-acting version of human growth hormone (hGH), containing the carboxy-terminal peptide (CTP) of human chorionic gonadotropin (hCG). MOD-4023 is being developed as a treatment for adults and children with growth hormone deficie
Publikováno v:
Clinical pharmacology in drug development. 7(5)
Daily injections of growth hormone (GH) as replacement therapy in GH-deficient (GHD) patients may cause poor compliance and inconvenience. C-terminal peptide-modified human GH (MOD-4023) has been developed for once-weekly administration in GHD adults
Publikováno v:
Endocrine Abstracts.
Autor:
Zvi Zadik, Oren Hershkovitz, Ron G. Rosenfeld, Julia Skorodok, Leanne Amitzi, Violeta Iotova, Oleg Malievsky, Gili Hart, Nataliya Zelinska, Ronit Koren, Klaudziya Radziuk
Publikováno v:
Endocrine Abstracts.
Autor:
Klaudziya Radziuk, Oleg Malievsky, Nataliya Zelinska, Oren Hershkovitz, Zvi Zadik, Leanne Amitzi, Gili Hart, Julia Skorodok, Ronit Koren, Ron G. Rosenfeld
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.